Understand the source comparison
Peptide Deals January 2026 Sales Promotions: Verification Standards Comparison
Growth Hormone Secretagogues (MK 677, Hexarelin, GHRP-2) $89–$135/5mg vial $72–$108/5mg vial 85–92% 4 weeks synthesis to verification 15–20% High-yield SPPS synthesis with streamlined verification makes these compounds ideal for January inventory rotation. Pri
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Growth Hormone Secretagogues (MK 677, Hexarelin, GHRP-2)
- $89–$135/5mg vial
- $72–$108/5mg vial
- 85–92%
- 4 weeks synthesis to verification
- 15–20%
- High-yield SPPS synthesis with streamlined verification makes these compounds ideal for January inventory rotation. Pricing reflects genuine production economics, not arbitrary markdowns.
- Metabolic Research Peptides (Tesofensine, Lipo C)
- $110–$165/vial
- $85–$132/vial
- 78–85%
- 5 weeks synthesis to verification
- 18–25%
- Moderate complexity synthesis with solid batch consistency. January promotions clear Q4 verified stock before Q1 metabolic research compound batches begin.
- Neuroprotective Compounds (Cerebrolysin, P21, Dihexa)
- $145–$220/vial
- $102–$154/vial
- 65–75%
- 6 weeks synthesis to verification
- 20–30%
- Lower batch yields and extended verification create higher baseline costs. Steepest January discounts reflect urgent inventory rotation needs for compounds with narrower research demand windows.
- Specialty Immune Peptides (Thymalin, Cartalax, KPV)
- $125–$185/vial
- $95–$133/vial
- 70–80%
- 5–6 weeks synthesis to verification
- 22–28%
- Limited production runs synthesised in specialized equipment batches. January deals reflect need to clear niche compound inventory before equipment shifts to higher-volume Q1 synthesis schedules.